NewsRx

Search our medical news database

Heart Attack

REFINE study enrollment completed

Published in Biotech Business Week, March 7th, 2005

Cambridge Heart (CAMH) announced that the Risk Estimation Following Infarction - Noninvasive Evaluation Study (REFINE) has completed its enrollment of 350 patients.

The multicenter Canadian study was led by Derek Exner, MD, University of Calgary Associate professor of Medicine, Libin Cardiovascular Institute of Alberta.

The study enrolled individuals who had experienced a recent myocardial infarction or heart attack. The patients also had impaired pumping efficiency of the heart as determined by an ejection fraction of 50% or less. All patients were being treated with optimal medical therapy.

In addition to Microvolt T-Wave...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook